Copyright
©The Author(s) 2021.
World J Clin Cases. Sep 16, 2021; 9(26): 7876-7885
Published online Sep 16, 2021. doi: 10.12998/wjcc.v9.i26.7876
Published online Sep 16, 2021. doi: 10.12998/wjcc.v9.i26.7876
Age | ALT | AST | IgG | IgA | IgM | Blood ammonia | Medication |
8 mo | 213 | 242 | 4.2 | 1.3 | 0.54 | 181 | Glutathione, ursodeoxycholic acid, ornithine monohydrate |
9 mo | 202 | 332 | 3.5 | 0.1 | 0.16 | 74 | Glutathione, compound glycyrrhizin |
11 mo | 388 | 515 | - | - | - | - | Glutathione, compound glycyrrhizin |
12 mo | 167 | 111 | 3.12 | 0.37 | 0.36 | 142 | Glutathione, compound glycyrrhizin, ornithine monohydrate |
19 mo | 128 | 196 | 2.16 | 0.32 | 0.09 | 95 | Bicyclol, compound glycyrrhizin |
- Citation: Yang X, Lv ZL, Tang Q, Chen XQ, Huang L, Yang MX, Lan LC, Shan QW. Congenital disorder of glycosylation caused by mutation of ATP6AP1 gene (c.1036G>A) in a Chinese infant: A case report. World J Clin Cases 2021; 9(26): 7876-7885
- URL: https://www.wjgnet.com/2307-8960/full/v9/i26/7876.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i26.7876